Framing and reframing the regulation of medicines
The Federal Official Gazette (DOU) published Resolution RDC No. 882/2024, which defines the criteria and procedures for classifying medicines as non-prescription or on prescription. Stay up to date with the new guidelines.
If you need more information on regulatory issues, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.
